Reltecimod
Reltecimod (AB-103) is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod can be used to research necrotizing soft-tissue infections (NSTIs) [1][2].
Product Specifications
CAS Number
1447799-33-8
Product Name Alternative
AB-103
UNSPSC
12352209
Target
Bacterial; CD28
Type
Peptides
Related Pathways
Anti-infection; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/reltecimod.html
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C46H72N10O15S
Molecular Weight
1037.19
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal EOGT/AER61 Antibody [DyLight 550]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
Rabbit Polyclonal EOGT/AER61 Antibody [DyLight 550]
TMEM88 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)